Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

AmBisome approved for marketing in Spain

April 12, 1996

Mentax approvable for athlete's foot

April 12, 1996

New antifungals isolated from actinomycetes at Schering-Plough

April 12, 1996

L-742728 selected by Merck & Co. for further evaluation

April 12, 1996

Virend entering phase III

April 5, 1996

Nabi foresees phase I/II trials on CMV NeutraGAM

April 5, 1996

Lidakol formulations receive patent protection

April 5, 1996

BILD-1351 for HSV infection

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.